Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Bhami Research Laboratory (BRL),
Worldwide patent granted for “High Concentration Protein Formulations with Reduced Viscosity” With this new patented technology that holds great potential
Dr. Bhami Shenoy envisions a bright future for biologics in India. With multiple patents, publications and grants under his belt,
Subcutaneous Trastuzumab Case: Achieving concentration of 250mg/mL at a syringeable viscosity of 18 cP. Using only 2 GRAS excipients, BRL
